Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of DW1026C1 or DW1026C2 [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of DW1026C1 or DW1026C2 for type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• DW1026C1
• DW1026C2

Snippet

Sponsor: Daewon Pharmaceutical Co., Ltd. | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED